> top > docs > PMC:1448208 > spans > 113-519 > annotations

PMC:1448208 / 113-519 JSONTXT

Annnotations TAB JSON ListView MergeView

craft-sa-dev

Id Subject Object Predicate Lexical cue
T850 0-10 sentence denotes Background
T851 0-10 NN denotes Background
T852 10-142 sentence denotes Maple Syrup Urine Disease (MSUD) is an inborn error of metabolism caused by a deficiency of branched-chain keto acid dehydrogenase.
T853 11-16 NN denotes Maple
T854 17-22 NN denotes Syrup
T855 29-36 NN denotes Disease
T856 23-28 NN denotes Urine
T857 44-46 VBZ denotes is
T858 37-38 -LRB- denotes (
T859 38-42 NN denotes MSUD
T860 42-43 -RRB- denotes )
T861 47-49 DT denotes an
T862 57-62 NN denotes error
T863 50-56 JJ denotes inborn
T864 63-65 IN denotes of
T865 66-76 NN denotes metabolism
T866 77-83 VBN denotes caused
T867 84-86 IN denotes by
T868 87-88 DT denotes a
T869 89-99 NN denotes deficiency
T870 100-102 IN denotes of
T871 103-111 VBN denotes branched
T872 112-117 NN denotes chain
T873 111-112 HYPH denotes -
T874 128-141 NN denotes dehydrogenase
T875 118-122 NN denotes keto
T876 123-127 NN denotes acid
T877 141-142 . denotes .
T878 142-225 sentence denotes MSUD has several clinical phenotypes depending on the degree of enzyme deficiency.
T879 143-147 NN denotes MSUD
T880 148-151 VBZ denotes has
T881 152-159 JJ denotes several
T882 169-179 NNS denotes phenotypes
T883 160-168 JJ denotes clinical
T884 180-189 VBG denotes depending
T885 190-192 IN denotes on
T886 193-196 DT denotes the
T887 197-203 NN denotes degree
T888 204-206 IN denotes of
T889 207-213 NN denotes enzyme
T890 214-224 NN denotes deficiency
T891 224-225 . denotes .
T892 225-316 sentence denotes Current treatments are not satisfactory and require new approaches to combat this disease.
T893 226-233 JJ denotes Current
T894 234-244 NNS denotes treatments
T895 245-248 VBP denotes are
T896 249-252 RB denotes not
T897 253-265 JJ denotes satisfactory
T898 266-269 CC denotes and
T899 270-277 VBP denotes require
T900 278-281 JJ denotes new
T901 282-292 NNS denotes approaches
T902 293-295 TO denotes to
T903 296-302 VB denotes combat
T904 303-307 DT denotes this
T905 308-315 NN denotes disease
T906 315-316 . denotes .
T907 316-406 sentence denotes A major hurdle in developing new treatments has been the lack of a suitable animal model.
T908 317-318 DT denotes A
T909 325-331 NN denotes hurdle
T910 319-324 JJ denotes major
T911 365-369 VBN denotes been
T912 332-334 IN denotes in
T913 335-345 VBG denotes developing
T914 346-349 JJ denotes new
T915 350-360 NNS denotes treatments
T916 361-364 VBZ denotes has
T917 370-373 DT denotes the
T918 374-378 NN denotes lack
T919 379-381 IN denotes of
T920 382-383 DT denotes a
T921 400-405 NN denotes model
T922 384-392 JJ denotes suitable
T923 393-399 NN denotes animal
T924 405-406 . denotes .
R13 T853 T854 compound Maple,Syrup
R14 T854 T855 compound Syrup,Disease
R15 T855 T857 nsubj Disease,is
R17 T858 T855 punct (,Disease
R18 T859 T855 appos MSUD,Disease
R19 T860 T857 punct ),is
R20 T861 T862 det an,error
R21 T862 T857 attr error,is
R23 T864 T862 prep of,error
R24 T865 T864 pobj metabolism,of
R25 T866 T862 acl caused,error
R26 T867 T866 agent by,caused
R27 T868 T869 det a,deficiency
R28 T869 T867 pobj deficiency,by
R29 T870 T869 prep of,deficiency
R30 T871 T872 amod branched,chain
R31 T872 T874 compound chain,dehydrogenase
R33 T874 T870 pobj dehydrogenase,of
R36 T877 T857 punct .,is
R37 T879 T880 nsubj MSUD,has
R38 T881 T882 amod several,phenotypes
R39 T882 T880 dobj phenotypes,has
R41 T884 T880 prep depending,has
R42 T885 T884 prep on,depending
R43 T886 T887 det the,degree
R44 T887 T885 pobj degree,on
R45 T888 T887 prep of,degree
R46 T889 T890 compound enzyme,deficiency
R47 T890 T888 pobj deficiency,of
R48 T891 T880 punct .,has
R49 T893 T894 amod Current,treatments
R50 T894 T895 nsubj treatments,are
R51 T896 T895 neg not,are
R52 T897 T895 acomp satisfactory,are
R53 T898 T895 cc and,are
R54 T899 T895 conj require,are
R55 T900 T901 amod new,approaches
R56 T901 T899 dobj approaches,require
R57 T902 T903 aux to,combat
R58 T903 T899 advcl combat,require
R59 T904 T905 det this,disease
R60 T905 T903 dobj disease,combat
R61 T906 T895 punct .,are
R62 T908 T909 det A,hurdle
R63 T909 T911 nsubj hurdle,been
R65 T912 T909 prep in,hurdle
R66 T913 T912 pcomp developing,in
R67 T914 T915 amod new,treatments
R68 T915 T913 dobj treatments,developing
R69 T916 T911 aux has,been
R70 T917 T918 det the,lack
R71 T918 T911 attr lack,been
R72 T919 T918 prep of,lack
R73 T920 T921 det a,model
R74 T921 T919 pobj model,of
R77 T924 T911 punct .,been
R16 T856 T855 compound Urine,Disease
R22 T863 T862 amod inborn,error
R32 T873 T872 punct -,chain
R34 T875 T876 compound keto,acid
R35 T876 T874 compound acid,dehydrogenase
R40 T883 T882 amod clinical,phenotypes
R64 T910 T909 amod major,hurdle
R75 T922 T921 amod suitable,model
R76 T923 T921 compound animal,model

craft-ca-core-ex-dev

Below, discontinuous spans are shown in the chain model. You can change it to the bag model.

Id Subject Object Predicate Lexical cue
T776 11-16 NCBITaxon:4022 denotes Maple
T777 23-28 UBERON:0001088 denotes Urine
T778 66-76 GO:0008152 denotes metabolism
T779 118-127 CHEBI:25754 denotes keto acid
T780 207-213 CHEBI_GO_SO_EXT:enzyme denotes enzyme
T781 393-399 NCBITaxon:33208 denotes animal

craft-ca-core-dev

Below, discontinuous spans are shown in the chain model. You can change it to the bag model.

Id Subject Object Predicate Lexical cue
T729 11-16 NCBITaxon:4022 denotes Maple
T730 23-28 UBERON:0001088 denotes Urine
T731 66-76 GO:0008152 denotes metabolism
T732 118-127 CHEBI:25754 denotes keto acid
T733 393-399 NCBITaxon:33208 denotes animal